Go to Main

Extraordinary General Meeting of Shareholders

Acot 12: Linking Lipid Metabolism to Renal Fibrosis with Therapeutic Implications(Experimental & Molecular Medicine, IF9.5)

Electrical and fluorescence in situ monitoring of tumor microenvironment-based pH-responsive polymer dot coated surface (Theranostics, IF5.6)

Establishment of a Corporate-Affiliated Research Center

Unveiling the crucial role of peroxisomal acyl-CoA metabolism in muscle atrophy: Insights from genetic models and therapeutic interventions (NANO TODAY, IF13.2)

Established as a corporation, spearheaded by academic innovation (Faculty-led Startup)

Tumor Microenvironment-Selective Sol-Gel Mineralization of ROS-Responsive Stretchable and Conductive Hydrogel (ADVANCED FUNCTIONAL MATERIALS, IF18.5)

Selected for the Pre-Startup Package by the Ministry of SMEs and Startups, marking our first step towards pioneering therapeutic advancements